Clinical Trial Update: Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating oral S-1 plus irinotecan (IRIS) in patients with advanced colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Hokkaido Gastrointestinal Cancer Study Group | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN